Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUNOSI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SUNOSI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

SUNOSI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Atnahs Pharma Netherlands Bv.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 12, 2021
Approval ID: fd67f40713b6c387
Company: Atnahs Pharma Netherlands Bv.
Type: Standard

Approval Details

Approval Id: fd67f40713b6c387
Drug Cima Aemps Name: SUNOSI 75 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1191408002
Holder Company Name: Atnahs Pharma Netherlands Bv.
Marketing Company Name: Jazz Pharmaceuticals Iberia S.L.
Authorization Date: 2021-02-12
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 75 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Atnahs Pharma Netherlands Bv.

Active Ingredients

SOLRIAMFETOL HIDROCLORURO

89,25 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 12, 2021

Approval ID

fd67f40713b6c387

Type

Standard

Back to CIMA-AEMPS Approvals